Home / Mumbai / Mumbai News / Article /
'Be realistic, we're in India': Bombay HC quashes FDA suspension of Navi Mumbai hotel's licence
Updated On: 31 July, 2026 01:08 PM IST | Mumbai | mid-day online correspondent
Granting relief to Park Inn by Radisson, a HC bench observed that while the hotel’s licence was initially suspended after the FDA found multiple hygiene deficiencies, the continued suspension could not be justified after the hotel achieved 95 per cent compliance in a court-directed inspection

The hotel approached the high court, contending that the FDA action was drastic and disproportionate. Representational Pic
The Bombay High Court has asked the Maharashtra Food and Drug Administration (FDA) to take a more pragmatic approach while enforcing food safety norms, observing that "we're in India", as it set aside the suspension of a four-star Navi Mumbai hotel's food licence over hygiene concerns.
Granting relief to Park Inn by Radisson, a bench of Acting Chief Justice Ravindra Ghuge and Justice Gautam Ankhad observed on Wednesday that while the hotel's licence was initially suspended following the FDA's inspection that found multiple hygiene-related deficiencies, the continued suspension could not be justified after the hotel substantially rectified the lapses and achieved 95 per cent compliance.


